NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Feb 26, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-02-25$1.91/sh+125,387$239,489→ 133,246 total
Footnotes (3)
- [F1]share ownership reflects the 25:1 reverse split effectuated by the company in December 2015
- [F2]Share acquisition pursuant to a securities purchase agreement, which is one of three securities purchase agreements that the company entered into for the sale of an aggregate of 1,518,567 shares of the Company's common stock to accredited investors.
- [F3]Price is equivalent to the closing price of one share of NovaBay common stock on the day the securities purchase agreement was signed, February 16, 2016.